Financial Comparison: Alignment Healthcare (NASDAQ:ALHC) & biote (NASDAQ:BTMD)

biote (NASDAQ:BTMD) and Alignment Healthcare (NASDAQ:ALHC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Valuation & Earnings

This table compares biote and Alignment Healthcare”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
biote	$192.22 million	0.22	$27.05 million	$0.11	10.64
Alignment Healthcare	$3.95 billion	0.46	-$720,000.00	$0.19	45.84

biote has higher earnings, but lower revenue than Alignment Healthcare. biote is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for biote and Alignment Healthcare, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
biote	1	1	1	1	2.50
Alignment Healthcare	0	4	7	0	2.64

biote presently has a consensus target price of $2.50, indicating a potential upside of 113.68%. Alignment Healthcare has a consensus target price of $23.00, indicating a potential upside of 164.06%. Given Alignment Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Alignment Healthcare is more favorable than biote.

Profitability

This table compares biote and Alignment Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
biote	3.19%	-22.33%	12.10%
Alignment Healthcare	0.89%	20.02%	3.46%

Volatility & Risk

biote has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

Institutional and Insider Ownership

21.7% of biote shares are owned by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are owned by institutional investors. 32.4% of biote shares are owned by company insiders. Comparatively, 5.2% of Alignment Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Alignment Healthcare beats biote on 9 of the 15 factors compared between the two stocks.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.